Psychedelic pharma’s big spin
…those who won’t tolerate paying ten or more times the market price for psychedelic materials…
…recently we have… witnessed a stream of breathless announcements put out by psychedelic pharma companies who hope to cash in on the popularity of the burgeoning psychedelic healing category… even after the air hissed out of the psychedelic industry investment balloon last year, you can still see many headlines like this meant to lure investors toward a questionable promised land of psychedelic therapy mega-profits. There are over 50 companies online who have gone public and are now trading stock. It’s a fever pitch out there. It’s also a big spin, PR on the fluff air setting… intrinsic problems will bedevil the psychedelic pharma companies. Patents are the profit lifeblood of pharma companies, but the new psychedelic pharma entities face the same dilemma as the big companies… they either must create novel molecules (which may or may not be safe), novel ways of making old drugs like LSD, or uses that others haven’t previously come up with…
Original Article (Lucid News):
Psychedelic pharma’s big spin
Artwork Fair Use: Armenak Margarian
Recent Comments